The FDA announced this week that it is modifying its approval criteria for drugs targeting early stage Alzheimer’s disease. The announcement highlights the fact that many researchers are refocusing their efforts to find drugs that prevent, rather than cure, Alzheimer’s disease.
Alzheimer’s disease is defined as a progressive, degenerative disorder of Read More…